About Instituto Atena de Pesquisa Clinica
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Instituto Atena de Pesquisa Clinica
During the past decade, Instituto Atena de Pesquisa Clinica conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Instituto Atena de Pesquisa Clinica" #1 sponsor was "Hospital Israelita Albert Einstein" with 2 trials, followed by "Amgen" with 1 trials
sponsored, "Clover Biopharmaceuticals AUS Pty Ltd" with 1 trials sponsored, "Hospital Alemão Oswaldo Cruz" with 1 trials sponsored and "Ottawa Heart Institute Research Corporation"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto Atena de Pesquisa Clinica"
#1 collaborator was "CytoDyn, Inc." with 2 trials as a collaborator, "Coalition for Epidemic Preparedness Innovations" with 1 trials as a collaborator, "Grupo Fleury" with 1 trials as a collaborator, "International Vaccine Institute" with 1 trials as a collaborator and "Ministry of Health, Brazil" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at Instituto Atena de Pesquisa Clinica
According to Clinical.Site data, the most researched conditions in "Instituto Atena de Pesquisa Clinica" are
"COVID-19" (2 trials), "COVID-19 Pneumonia" (2 trials), "Cardiovascular Diseases" (2 trials), "Acute MI" (1 trials) and "Atherosclerotic Cardiovascular Disease" (1 trials). Many other conditions were trialed in "Instituto Atena de Pesquisa Clinica" in a lesser frequency.
Clinical Trials Intervention Types at Instituto Atena de Pesquisa Clinica
Most popular intervention types in "Instituto Atena de Pesquisa Clinica" are "Drug" (3 trials), "Biological" (1 trials), "Genetic" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Leronlimab" (2 trials), "Placebo" (2 trials), "Angiotensin II Receptor Blockers" (1 trials), "Angiotensin converting enzyme inhibitor" (1 trials) and "CpG 1018/Alum-adjuvanted SCB-2019 vaccine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Instituto Atena de Pesquisa Clinica
The vast majority of trials in "Instituto Atena de Pesquisa Clinica" are
6 trials for "All" genders.
Clinical Trials Status at Instituto Atena de Pesquisa Clinica
Currently, there are NaN active trials in "Instituto Atena de Pesquisa Clinica".
undefined are not yet recruiting,
3 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Instituto Atena de Pesquisa Clinica,
2 suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Instituto Atena de Pesquisa Clinica, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".